In addition, the expression of FOXp3 in our study (along with CD3 and CD204) was significantly correlated with a shorter DFI in comparison to tumors lacking FOXp3, suggesting a significant role of T-regulatory cells on STS progression. The gene discussed is FOXP3; the disease is telomere syndrome.